Wirtz, Paul W <br/><br/>
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.  [electronic resource] 

 -  Expert review of clinical immunology  Nov 2010 
 - 867-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8409 
<br/><br/><label>Standard No.: </label>10.1586/eci.10.57  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4-Aminopyridine--adverse effects<br/>Action Potentials--drug effects<br/>Amifampridine<br/>Calcium Channels--metabolism<br/>Cholinergic Agents--adverse effects<br/>Clinical Protocols<br/>Epilepsy--etiology<br/>Humans<br/>Lambert-Eaton Myasthenic Syndrome--drug therapy<br/>Muscles--drug effects<br/>Paresthesia--etiology<br/>Presynaptic Terminals--drug effects<br/>Randomized Controlled Trials as Topic